Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

Anti-GD(2) with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia.

Sorkin LS, Otto M, Baldwin WM 3rd, Vail E, Gillies SD, Handgretinger R, Barfield RC, Ming Yu H, Yu AL.

Pain. 2010 Apr;149(1):135-42. doi: 10.1016/j.pain.2010.01.024. Epub 2010 Feb 19.

2.

Combination therapy with interleukin-2 and antitumor monoclonal antibodies.

Sondel PM, Hank JA.

Cancer J Sci Am. 1997 Dec;3 Suppl 1:S121-7. Review.

PMID:
9457407
3.

Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies.

Parsons K, Bernhardt B, Strickland B.

Ann Pharmacother. 2013 Feb;47(2):210-8. doi: 10.1345/aph.1R353. Epub 2013 Feb 5. Review.

PMID:
23386066

Supplemental Content

Support Center